Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 
Online Report Subscribers, Click Here

Pricing and Ordering Information
ClearState

India Market for Interventional Cardiology Products
Report #CS200IN -
June 2009


The market for interventional cardiology products in India is growing in line with a dramatic rise in cardiovascular disease among increasingly affluent and urbanised Indians with a resulting surge in demand for high quality cardiac care. Established interventional cardiology procedures—diagnostic angiography, PTCA and coronary stenting, among others—are performed widely in India, across medium-sized and larger hospitals equipped with catheterisation laboratories. More advanced procedures and devices are concentrated at large corporate and private hospitals in key metropolitan cities.

An estimated 28.9 million Indians suffer from at least one cardiovascular disease or disorder with disease prevalence tripling over the past 30 years. The overall interventional cardiology products market in India will experience strong growth from approximately $249.3 million in 2008 to an estimated $635.7 million in 2012, an estimated compound annual growth rate of 26.4%. Key demand drivers include a surge in disease incidence due to affluence and lifestyle changes, resulting increase in demand for diagnosis and treatment, and infrastructure expansion driven partly by a fast-growing cluster of corporate hospitals, among other factors. The main constraints to growth remain high device and procedure costs, uneven infrastructure and skill levels across hospitals, and a persistent tendency to re-use disposable devices.

This report analyzes the following diagnostic and therapeutic interventional cardiology procedures and associated product groups: coronary angiography; intravascular ultrasound (IVUS); balloon valvuloplasty; chronic total occlusion (CTO) crossing; embolic protection; mechanical atherectomy; percutaneous transluminal coronary angioplasty and stenting; thrombectomy; transcatheter septal defect repair; and vascular puncture closure (VPC).

Ordering Information

Title

Report# Publication
Date
List Price

India Market for Interventional Cardiology Products

CS200IN

June 2009

$5,950

Order Online:
Single User only (Please call for corporate subscription pricing)
    PDF Only

Save $100 off the regular print only price when you order online.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

1. EXECUTIVE SUMMARY

1.1. Interventional cardiology procedures and devices

1.2. Interventional cardiology products market

1.3. Methodology

 

2. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES AND DISORDERS

2.1. Cardiovascular system: structure and function

2.2. Vascular diseases and disorders

2.2.1. Atherosclerosis

2.2.2. Coronary heart disease

2.2.2.1. Angina pectoris

2.2.2.2. Myocardial infarction

2.3. Myocardial diseases and disorders

2.3.1. Congestive heart failure

2.3.2. Rheumatic fever / Rheumatic heart disease

2.3.3. Heart valve disorders

2.3.4. Congenital cardiovascular defects

 

3. INTERVENTIONALCARDIOLOGY PROCEDURES

3.1. Diagnostic procedures

3.1.1. Coronary angiography

3.1.1.1. Indications

3.1.1.2. Procedure volumes

3.1.2. Intravascular ultrasound

3.1.2.1. Indications

3.1.2.2. Procedure volumes

3.2. Therapeutic procedures

3.2.1. Percutaneous Transluminal Coronary Angioplasty

3.2.1.1. Indications

3.2.1.2. Procedure volumes

3.2.2. Coronary stenting

3.2.2.1. Indications

3.2.2.2. Types of stents

3.2.2.3. Procedure volumes

3.2.3. Mechanical thrombectomy

3.2.3.1. Indications

3.2.3.2. Procedure volumes

3.2.4. Chronic total occlusion crossing

3.2.4.1. Indications

3.2.4.2. Procedure volumes

3.2.5. Embolic protection

3.2.5.1. Indications

3.2.5.2. Procedure volumes

3.2.6. Percutaneous Balloon Valvuloplasty

3.2.6.1. Indications

3.2.6.2. Procedure volumes

3.2.7. Transcatheter septal defect repair

3.2.7.1. Indications

3.2.7.2. Procedure volumes

3.2.8. Vascular access site closure

3.2.8.1. Indications

3.2.8.2. Procedure volumes

 

4. INTERVENTIONAL CARDIOLOGY PRODUCTS MARKET

4.1. Diagnostic interventional cardiology products

4.1.1. Coronary angiography devices

4.1.1.1. Device types and available products

4.1.1.2. Market size and forecast

4.1.2. Intravascular ultrasound devices

4.1.2.1. Device types and available products

4.1.2.2. Market size and forecast

4.2. Therapeutic interventional cardiology products

4.2.1. Percutaneous transluminal coronary angioplasty devices

4.2.1.1. Device types and available products

4.2.1.2. Market size and forecast

4.2.2. Coronary stenting devices

4.2.2.1. Device types and available products

4.2.2.2. Market size and forecast

4.2.3. Mechanical thrombectomy devices

4.2.3.1. Device types and available products

4.2.3.2. Market size and forecast

4.2.4. Chronic total occlusion crossing devices

4.2.4.1. Device types and available products

4.2.4.2. Market size and forecast

4.2.5. Embolic protection devices

4.2.5.1. Device types and available products

4.2.5.2. Market size and forecast

4.2.6. Percutaneous balloon valvuloplasty devices

4.2.6.1. Device types and available products

4.2.6.2. Market size and forecast

4.2.7. Transcatheter septal defect repair devices

4.2.7.1. Device types and available products

4.2.7.2. Market size and forecast

4.2.8. Vascular access site closure devices

4.2.8.1. Device types and available products

4.2.8.2. Market size and forecast

 

5. INTERVENTIONAL CARDIOLOGY PRODUCTS SUPPLIERS

5.1. Coronary angiography

5.2. Percutaneous coronary angioplasty devices

5.3. Coronary stenting

 

6. COMPANY PROFILES

6.1.   Abbott Vascular

6.2.   Boston Scientific

6.3.   Cordis / Johnson & Johnson

6.4.   Medtronic, Inc.

6.5.   Sahajanand Medical Technologies Pvt Ltd

6.6.   St.  Jude Medical, Inc.

6.7.   Terumo Medical

6.8.   Vascular Concepts

 

7. HOSPITAL PROFILES

7.1.   All India Institute of Medical Sciences (AIIMS)

7.2.   Asian Heart Institute

7.3.   Fortis / Escorts Healthcare

7.4.   Indraprastha Apollo Hospital

7.5.   Max Heart and Vascular Institute

7.6.   Narayana Hrudayalaya

Clearstate is a market intelligence firm offering customized strategic advisory and primary research solutions specifically addressing the Healthcare and Life Sciences domains within the Asia Pacific region. www.clearstate.com

*The pdf version of each report costs an additional $750 when purchased in addition to the hardcopy.

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact sales@medtechinsight.com. From outside the U.S., contact internationalsales@medtechinsight.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home